NYSE : MPT

Medical Properties Trust, Inc. — Financial statements

United States

Last price 2.25 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 1.34B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

Income statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Rental Revenue947.89M888.71M883.16M675.48M1.17B1.17B
Other Revenue70.57M110.15M57.85M13.97M40.80M28.49M
Total Revenue1.09B1.07B1.04B885.77M1.58B1.57B
Property Expenses47.22M41.57M32.88M47.22M45.70M39.10M
Selling, General & Administrative115.44M125.27M128.16M139.94M160.49M145.64M
Depreciation & Amortization276.64M265.40M447.66M603.36M332.98M321.25M
Total Operating Expenses439.30M432.25M608.70M827.91M539.17M505.99M
Operating Income650.80M637.63M430.99M57.85M1.04B1.07B
Interest Expense-554.14M-510.36M-417.82M-411.17M-359.04M-367.39M
Other Non-Operating Income170.10M-12.05M-439.26M7.59M15.34M45.70M
EBT Excluding Unusual Items266.76M115.21M-426.10M-345.73M700.79M745.48M
Gain (Loss) on Sale of Investments-147.00M-147.00M-1.19B
Gain (Loss) on Sale of Assets164.83M5.54M478.69M-1.81M536.75M52.47M
Asset Writedown-94.33M-193.95M-1.18B-339.51M-268.38M-39.41M
Other Unusual Items56.02M-17.13M-55.59M285.00K-9.45M-27.65M
Pretax Income246.28M-237.32M-2.36B-686.77M959.72M730.89M
Income Tax Expense-4.21M38.62M44.10M-130.68M55.90M73.95M
Earnings From Continuing Operations250.49M-275.94M-2.41B-556.09M903.82M656.94M
Minority Interest in Earnings-1.36M-1.11M-1.98M-384.00K-1.22M-919.00K
Net Income249.13M-277.05M-2.41B-556.48M902.60M656.02M
Preferred Dividends & Other Adjustments1.51M889.00K946.00K1.64M1.60M2.16M
Net Income to Common247.62M-277.94M-2.41B-558.12M901.00M653.86M
Basic Shares Outstanding598.45M600.89M600.25M598.52M598.63M588.82M
Diluted Shares Outstanding598.45M600.89M600.25M598.52M598.84M590.14M
EPS (Basic)0.41-0.46-4.02-0.931.511.11
EPS (Diluted)0.41-0.46-4.02-0.931.501.11
Dividend Per Share0.360.330.460.881.161.12
Operating Margin59.70%59.60%41.45%6.53%65.95%67.84%
Profit Margin22.71%-25.98%-231.92%-63.01%56.89%41.56%
EBITDA941.35M910.44M714.74M387.98M1.39B1.40B
EBITDA Margin86.35%85.10%68.75%43.80%87.78%89.05%
D&A For Ebitda290.55M272.82M283.75M330.13M345.58M333.78M
EBIT650.80M637.63M430.99M57.85M1.04B1.07B
EBIT Margin59.70%59.60%41.45%6.53%65.95%67.84%
Funds From Operations (FFO)466.73M183.92M-1.40B287.79M934.31M975.99M
FFO Per Share0.31-2.330.481.561.65
Adjusted Funds From Operations (AFFO)183.92M-1.40B287.79M850.06M975.99M
FFO Payout Ratio105.08%213.83%74.76%65.93%
Effective Tax Rate5.83%10.12%
Revenue as Reported1.03B972.02M995.55M871.80M1.54B1.54B

Balance sheet

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Property, Plant & Equipment10.15B9.91B9.25B11.00B11.49B11.80B
Cash & Equivalents599.28M540.86M332.33M250.02M235.67M459.23M
Accounts Receivable1.35B1.32B1.79B1.91B2.65B2.84B
Investment In Debt and Equity Securities320.74M322.18M439.58M1.78B1.44B1.29B
Other Intangible Assets647.91M602.78M854.46M1.21B1.28B
Loans Receivable Current283.01M186.29M109.17M292.62M227.84M67.32M
Restricted Cash5.87M2.65M
Other Current Assets170.38M148.41M130.71M272.42M1.18B
Trading Asset Securities43.00M93.20M
Deferred Long-Term Charges3.27M5.67M8.51M12.04M5.49M
Other Long-Term Assets1.56B1.77B1.49B1.73B1.66B1.38B
Total Assets14.39B15.00B14.29B18.30B19.66B20.52B
Current Portion of Long-Term Debt587.30M1.13B453.65M483.32M4.20M
Current Portion of Leases7.24M101.59M
Long-Term Debt9.26B9.11B7.71B9.61B9.79B11.28B
Long-Term Leases66.69M80.52M103.75M1.94M87.15M
Accounts Payable398.70M549.11M454.21M412.18M621.32M603.59M
Long-Term Unearned Revenue16.93M19.29M29.45M37.96M27.73M25.56M
Other Long-Term Liabilities95.38M54.37M48.52M52.85M42.60M70.85M
Total Liabilities9.77B10.39B9.46B10.67B11.06B12.07B
Common Stock597.00K597.00K600.00K599.00K597.00K597.00K
Additional Paid-In Capital8.58B8.57B8.58B8.56B8.54B8.56B
Retained Earnings-4.07B-4.14B-3.66B-971.81M116.28M-87.69M
Comprehensive Income & Other104.41M168.21M-94.27M42.50M-59.18M-36.73M
Total Common Equity4.62B4.61B4.83B7.63B8.59B8.44B
Minority Interest1.05M1.05M1.05M2.27M1.57M5.48M
Shareholders' Equity4.62B4.61B4.83B7.63B8.59B8.45B
Total Liabilities & Equity14.39B15.00B14.29B18.30B19.66B20.52B
Total Debt9.26B9.77B8.93B10.17B10.37B11.37B
Net Cash (Debt)-8.66B-9.23B-8.60B-9.87B-10.04B-10.91B
Net Cash Per Share-14.47-15.36-14.32-16.50-16.77-18.50
Filing Date Shares Outstanding597.16M597.70M600.60M599.10M598.30M596.75M
Total Common Shares Outstanding597.16M597.01M600.40M598.99M597.48M596.75M
Book Value Per Share7.747.728.0512.7414.3814.14
Tangible Book Value4.62B3.96B4.23B6.78B7.38B7.16B
Tangible Book Value Per Share7.746.637.0511.3112.3612.00
Land1.74B1.56B1.74B1.88B1.89B
Buildings9.54B8.85B10.40B10.52B10.58B
Construction In Progress101.44M

Cash flow statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income-277.05M-2.41B-556.48M902.60M656.02M
Depreciation & Amortization272.82M283.75M330.13M345.58M333.78M
Other Amortization26.28M17.35M15.78M17.05M16.86M
Gain (Loss) on Sale of Assets-5.54M-478.69M1.81M-536.75M-52.47M
Gain (Loss) on Sale of Investments410.79M-40.95M
Asset Writedown193.95M2.00B662.91M268.38M39.41M
Stock-Based Compensation25.75M32.98M33.25M49.42M52.11M
Change in Accounts Receivable7.11M2.78M-141.73M-116.42M-23.87M
Change in Accounts Payable21.68M23.48M-4.60M33.58M54.06M
Change in Other Net Operating Assets14.97M-36.11M13.75M-4.03M-4.38M
Other Operating Activities-39.59M409.79M143.40M-220.42M-206.23M
Operating Cash Flow230.77M245.48M505.79M739.01M811.66M
Acquisition of Real Estate Assets-295.85M-341.48M-643.78M-1.65B-5.71B
Sale of Real Estate Assets120.55M1.85B897.50M2.19B246.47M
Net Sale / Acq. of Real Estate Assets-175.29M1.51B253.72M535.98M-5.46B
Investment in Marketable & Equity Securities11.66M12.43M14.29M65.55M
Investing Cash Flow-264.74M1.32B517.56M396.06M-3.86B
Long-Term Debt Issued2.75B804.19M567.91M332.11M3.97B
Long-Term Debt Repaid-2.25B-1.83B-988.16M-869.61M-1.39B
Net Debt Issued (Repaid)501.77M-1.03B-420.25M-537.49M2.58B
Issuance of Common Stock1.05B
Repurchase of Common Stock-25.91M-3.81M-8.08M-47.86M
Common Dividends Paid-193.26M-321.08M-615.39M-698.53M-643.47M
Other Financing Activities-54.51M-125.56M23.39M-58.63M-36.67M
Foreign Exchange Rate Adjustments14.71M-5.22M11.40M-12.89M4.66M
Net Cash Flow208.82M79.22M14.41M-220.34M-94.49M
Levered Free Cash Flow872.73M667.87M764.83M1.80B451.22M
Unlevered Free Cash Flow1.17B911.66M1.01B2.00B663.99M
Cash Interest Paid445.31M412.67M391.96M347.38M323.12M
Change in Working Capital34.15M-15.60M-125.01M-86.83M13.12M

Ratios

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization1.34B3.01B2.37B2.94B6.66B14.09B
Enterprise Value10.00B12.23B11.31B12.76B15.84B24.33B
Last Close Price2.254.703.483.947.9315.55
Price/FFO Ratio15.18-1.498.205.089.42
PE Ratio5.447.3921.55
PS Ratio1.232.812.283.324.218.96
PB Ratio0.290.650.490.390.781.67
P/OCF Ratio5.9213.039.665.819.0117.36
EV/Sales Ratio9.1811.4310.8814.4010.0015.46
EV/EBITDA Ratio10.6313.4315.8332.8811.3917.36
EV/EBIT Ratio15.3719.1826.25220.5015.1722.80
Debt / Equity Ratio2.002.121.851.331.211.35
Debt / EBITDA Ratio9.8210.7112.4626.097.428.08
Net Debt / Equity Ratio1.872.001.781.291.171.29
Net Debt / EBITDA Ratio9.2010.1412.0325.457.227.79
Asset Turnover0.070.070.060.050.080.08
Quick Ratio4.881.631.342.552.475.42
Current Ratio5.591.941.503.042.887.49
Return on Equity (ROE)5.40%-5.85%-38.63%-6.85%10.61%8.32%
Return on Assets (ROA)2.77%2.72%1.65%0.19%3.25%3.57%
Return on Invested Capital (ROIC)4.63%4.53%2.73%0.32%5.07%5.30%
Earnings Yield18.39%-9.21%-101.63%-18.94%13.55%4.66%
Dividend Yield16.00%6.55%11.65%17.94%10.40%4.74%
Payout Ratio87.01%77.39%98.09%
Buyback Yield / Dilution0.38%-0.11%-0.29%0.05%-1.47%-11.25%
Total Shareholder Return16.38%6.44%11.36%17.99%8.93%-6.51%